# TMS for the Treatment of Primary Progressive Aphasia

> **NCT04188067** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 10 (actual)

## Conditions studied

- Logopenic Variant Primary Progressive Aphasia
- Non-fluent Variant Primary Progressive Aphasia
- Semantic Variant Primary Progressive Aphasia

## Interventions

- **DEVICE:** Active rTMS
- **DEVICE:** SHAM rTMS

## Key facts

- **NCT ID:** NCT04188067
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2024-08-25
- **Final completion:** 2024-08-25
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04188067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04188067, "TMS for the Treatment of Primary Progressive Aphasia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04188067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*